- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 19-03-2026: Press Release
19-03-2026 | 08:37 am
19-03-2026 | 08:37 am
Glenmark Pharma Inc. USA launched an authorized generic for Milnacipran Hydrochloride Tablets, targeting the Savella® market. This market generates annual sales of ~$102.9 million, providing Glenmark with a new revenue opportunity and affordable alternative.
No comments yet. Be the first to comment!